Department of Surgery, School of Medicine, Ewha Womans University, Seoul, Korea.
J Gastric Cancer. 2010 Dec;10(4):226-33. doi: 10.5230/jgc.2010.10.4.226. Epub 2010 Dec 31.
In resectable gastric cancer, choice regarding the extent of resection depends on tumor size, location, and distance from resection margin. However, there remains controversy for choice of resection for tumors in the middle third of the stomach. This study investigated patients who underwent gastrectomy in order to analyze the differences between total gastrectomy (TG) and subtotal gastrectomy (STG).
From 2000 to 2006, 125 patients with a tumor in the middle third of the stomach underwent radical gastric resection at EUMC. We retrospectively conducted comparative analysis for the differences in clinicopathological characteristics and prognosis between TG and STG.
The average tumor size was 6.7 cm for TG, and 4.1 cm for STG. The number of metastatic lymph nodes were 13.3 for TG, and 3.7 for STG. Patients with more advanced cancer were more likely to receive TG. The 5-year survival rate for TG was lower (38.1%) than STG (69.0%). However, if tumor stages were stratified, there was no significant difference in the survival rate. Histologically, for the undifferentiated type of cancer (Stage 1, 2), the 5-year survival rate of STG was higher (88.1%) than TG (75.0%).
Comparing patients with tumors in the middle third of the stomach who underwent TG and STG, there was no statistically significant difference in the 5-year survival rate. If stages were stratified, the clinicopathological characteristic becomes a key factor in deciding the prognosis, rather than the choice of resection. Thus if the radical resection margin can be obtained for a tumor in the middle third of the stomach, STG is considered instead of TG.
在可切除的胃癌中,切除范围的选择取决于肿瘤的大小、位置和距切除边缘的距离。然而,对于胃中三分之一部位肿瘤的切除选择仍存在争议。本研究对接受胃切除术的患者进行了调查,以分析全胃切除术(TG)和胃次全切除术(STG)之间的差异。
2000 年至 2006 年,在 EUMC 接受根治性胃切除术的 125 名胃中三分之一部位肿瘤患者。我们回顾性地对 TG 和 STG 之间在临床病理特征和预后方面的差异进行了比较分析。
TG 的平均肿瘤大小为 6.7cm,STG 的平均肿瘤大小为 4.1cm。TG 的转移淋巴结数为 13.3 个,STG 的转移淋巴结数为 3.7 个。进展期癌症患者更有可能接受 TG。TG 的 5 年生存率(38.1%)低于 STG(69.0%)。然而,如果对肿瘤分期进行分层,生存率没有显著差异。组织学上,对于未分化型癌症(Ⅰ期、Ⅱ期),STG 的 5 年生存率(88.1%)高于 TG(75.0%)。
比较接受 TG 和 STG 治疗的胃中三分之一部位肿瘤患者,5 年生存率无统计学差异。如果对分期进行分层,临床病理特征成为决定预后的关键因素,而不是切除方式的选择。因此,如果可以获得胃中三分之一部位肿瘤的根治性切除边缘,考虑行 STG 而不是 TG。